The incidence of end-stage renal diseases (ESRDs) appears to be increasing in the world.
Dialysis and renal transplantation are possible treatments for patients with ESRD. 1 Renal …

Mesenchymal stem cells (MSCs) are multipotent cells and can be induced in vitro and in
vivo to differentiate not only into the variety of mesodermal cells, but into either ectodermal or …

The future use of adult mesenchymal stem cells (MSCs) for human therapies depends on
the establishment of preclinical studies with other mammals such as mouse. Surprisingly …

Prenatal transplantation of stem cells is an exciting frontier for the treatment of many
congenital diseases. The fetus may be an ideal recipient for stem cells, as it is …

Clinical trials utilizing bone marrow-derived mesenchymal stem cell (BM-MSC) therapies
show promise for treating a variety of pathologic conditions. Paramount to optimization of …

Tissue engineering has been extensively investigated and proffered to be a potential
platform for novel tissue regeneration. The utilization of mesenchymal stem cells (MSCs) …

Bone marrow is a major source of mesenchymal stem cells (MSC), which are used in tissue
engineering and other autologous stem cell therapies. Studies designed to use large canine …

OBJECTIVE: Mesenchymal stem cells (MSCs) have been studied in regenerative medicine
because of their unique immunologic characteristics. However, before clinical application in …

Mesenchymal stem cells have demonstrated their potentiality for therapeutic use in treating
diseases or repairing damaged tissues. However, in some cases, the results of clinical trials …

Mesenchymal stem cells (MSCs) are multipotent cells that exist in mesenchymal tissues
such as bone marrow and are able to differentiate into osteocytes, chondrocytes, and …